{"transactions":[{"id":729569,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:50:11.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":14180,"derivative":{"underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001104659-26-076923","document":"tm2618639-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076923/tm2618639-2_4seq1.xml","form_type":"4"}},{"id":729568,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T23:50:11.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":21270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":21270,"derivative":{"exercise_price":9.13,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":21270},"source":{"system":"sec-edgar","filing":"0001104659-26-076923","document":"tm2618639-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076923/tm2618639-2_4seq1.xml","form_type":"4"}},{"id":847066,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:00:14.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":7947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs subject to this grant under the Restated 2015 Stock Incentive Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of March 10, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date"}],"balance_after":15893,"derivative":{"exercise_price":0,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":7947},"source":{"system":"sec-edgar","filing":"0001104659-26-027143","document":"tm268599-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926027143/tm268599-1_4seq1.xml","form_type":"4"}},{"id":847065,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T21:00:14.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":7947,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7947,"source":{"system":"sec-edgar","filing":"0001104659-26-027143","document":"tm268599-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926027143/tm268599-1_4seq1.xml","form_type":"4"}},{"id":1210691,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-13T00:04:38.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":23840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":23840,"derivative":{"underlying":"Common Stock","underlying_shares":23840},"source":{"system":"sec-edgar","filing":"0001104659-25-023077","document":"tm259047-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925023077/tm259047-2_4seq1.xml","form_type":"4"}},{"id":1210690,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-03-13T00:04:38.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":35770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the March 10, 2025 grant date (the \"Grant Date\"), in each case subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":35770,"derivative":{"exercise_price":8.2,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":35770},"source":{"system":"sec-edgar","filing":"0001104659-25-023077","document":"tm259047-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925023077/tm259047-2_4seq1.xml","form_type":"4"}},{"id":1632414,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T19:41:57.000Z","date":"2024-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted for no consideration."}],"balance_after":0,"derivative":{"exercise_price":22.5,"underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000950170-24-017407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000095017024017407/ownership.xml","form_type":"4"}},{"id":1632413,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T19:41:57.000Z","date":"2024-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":9.89,"underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000950170-24-017407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000095017024017407/ownership.xml","form_type":"4"}},{"id":1632412,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T19:41:57.000Z","date":"2024-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.25,"underlying":"Common Stock","underlying_shares":9643},"source":{"system":"sec-edgar","filing":"0000950170-24-017407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000095017024017407/ownership.xml","form_type":"4"}},{"id":1632411,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-20T19:41:57.000Z","date":"2024-02-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2833,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\"). Pursuant to the Merger Agreement, immediately prior to the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive the Offer Price, subject to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents restricted stock units (\"RSUs\"). Pursuant to the Merger Agreement, immediately prior to the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive the Offer Price, subject to the terms of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-017407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000095017024017407/ownership.xml","form_type":"4"}},{"id":1632410,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-20T19:41:57.000Z","date":"2024-02-19","kind":"other","planned":false,"acquired":false,"shares":8066,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of December 11, 2023 (the \"Merger Agreement\"), by and among the Issuer, AstraZeneca Finance and Holdings Inc. (\"Parent\"), and Isochrone Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock at a purchase price per share of (i) $15.00 plus (ii) one non-tradable contingent value right (\"CVR\") per share representing the right to receive a contingent payment of up to $5.00 in cash upon achievement of specified milestones (collectively, the \"Offer Price\"). After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of February 19, 2024 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-017407","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000095017024017407/ownership.xml","form_type":"4"}},{"id":1861676,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T16:42:41.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 6, 2023, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":9.89,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-23-035454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919123035454/doc4.xml","form_type":"4"}},{"id":2232161,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T17:03:40.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":9643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 10, 2022, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":9643,"derivative":{"exercise_price":6.25,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":9643},"source":{"system":"sec-edgar","filing":"0001209191-22-036742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122036742/doc4.xml","form_type":"4"}},{"id":2232160,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T17:03:40.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which will vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date."}],"balance_after":10899,"source":{"system":"sec-edgar","filing":"0001209191-22-036742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122036742/doc4.xml","form_type":"4"}},{"id":2442527,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T19:34:08.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/36th of the shares subject to the option vest monthly following January 3, 2022, the vesting commencement date."}],"balance_after":25500,"derivative":{"exercise_price":22.5,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001209191-22-002000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122002000/doc4.xml","form_type":"4"}},{"id":2442526,"issuer":{"id":94107,"kind":"organization","name":"Icosavax, Inc.","symbol":"ICVX"},"owners":[{"id":36115,"kind":"person","name":"Shiver John W.","position":1,"cik":"0001900372","reported_name":"Shiver John W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T19:34:08.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on January 3, 2022. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 3, 2022, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate upon a Change of Control (as defined in the Icosavax, Inc. 2021 Incentive Award Plan). Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001209191-22-002000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786255/000120919122002000/doc4.xml","form_type":"4"}}]}